Chitranjan S. Ranawat奖:麻醉下手法松解治疗全膝关节置换术后僵硬:一项多中心随机临床试验
这项多中心随机临床试验纳入15家机构的124例初次全膝关节置换术后僵硬患者,在术后4至12周活动度小于90°时行麻醉下手法松解,比较加用静脉地塞米松8 mg及口服塞来昔布200 mg共14天与单纯手法松解加物理治疗的效果。结果显示两组在6周和1年时活动度及临床结局均相似,但手法松解本身使活动度即刻平均改善46°。
要点
- 麻醉下手法松解后活动度即刻平均改善46°,6周时改善28°,1年时改善37°。
- 加用静脉地塞米松8 mg和口服塞来昔布200 mg共14天未改善6周和1年活动度或临床结局。
- 术后4至12周活动度小于90°时行手法松解,两组6周活动度101°对99°(P=0.35),1年108°对108°(P=0.98)。
核心结论
- 在全膝关节置换术后僵硬患者中,麻醉下手法松解后加用静脉地塞米松和短期口服塞来昔布未改善活动度或临床结局。
- 麻醉下手法松解本身使活动度即刻平均改善46°、6周时改善28°、1年时改善37°。
- 关于抗炎药物的剂量、疗程和给药途径,仍需进一步研究。
研究设计与样本
- 多中心随机临床试验,纳入15家机构的124例患者(124例全膝关节置换),均为骨关节炎行初次全膝关节置换术后出现僵硬。
- 所有患者在术后4至12周活动度小于90°时接受麻醉下手法松解,采用置换区组设计随机分组。
- 对照组接受麻醉下手法松解和物理治疗,治疗组额外接受麻醉下手法松解前单次静脉地塞米松8 mg及口服塞来昔布200 mg共14天。
- 在术后6周和1年评估活动度和临床结局,试验在ClinicalTrials.gov注册。
- 证据等级为1级随机对照试验。
主要发现
- 麻醉下手法松解后活动度即刻从术前平均72°改善至118°,平均改善46°(P<0.001)。
- 术后6周活动度治疗组101°对对照组99°(P=0.35),两组相似。
- 术后1年活动度治疗组108°对对照组108°(P=0.98),两组相似。
- 两个时间点的临床结局在两组间均相似。
局限性
- 关于抗炎药物的剂量、疗程和给药途径,仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Manipulation under anesthesia (MUA) occurs in 4% of patients after total knee arthroplasty (TKA). Anti-inflammatory medications may target arthrofibrosis pathogenesis, but the data are limited. This multicenter randomized clinical trial investigated the effect of adjuvant anti-inflammatory medications with MUA and physical therapy on range of motion (ROM) and outcomes. METHODS: There were 124 patients (124 TKAs) who developed stiffness after primary TKA for osteoarthritis enrolled across 15 institutions. All received MUA when ROM was < 90° at 4 to 12 weeks postoperatively. Randomization proceeded via a permuted block design. Controls received MUA and physical therapy, while the treatment group also received one dose of pre-MUA intravenous dexamethasone (8 mg) and 14 days of oral celecoxib (200 mg). The ROM and clinical outcomes were assessed at 6 weeks and 1 year. This trial was registered with ClinicalTrials.gov. RESULTS: The ROM significantly improved a mean of 46° from a pre-MUA ROM of 72 to 118° immediately after MUA (P < .001). The ROM was similar between the treatment and control groups at 6 weeks following MUA (101 versus 99°, respectively; P = .35) and at one year following MUA (108 versus 108°, respectively; P = .98). Clinical outcomes were similar at both end points. CONCLUSIONS: In this multicenter randomized clinical trial, the addition of intravenous dexamethasone and a short course of oral celecoxib after MUA did not improve ROM or outcomes. However, MUA provided a mean ROM improvement of 46° immediately, 28° at 6 weeks, and 37° at 1 year. Further investigation in regards to dosing, duration, and route of administration of anti-inflammatory medications remains warranted. LEVEL OF EVIDENCE: Level 1, RCT.
引用
- Abdel MP, Salmons HI, Larson DR, et al. The Chitranjan S. Ranawat Award: Manipulation Under Anesthesia to Treat Postoperative Stiffness After Total Knee Arthroplasty: A Multicenter Randomized Clinical Trial. J Arthroplasty. 2024. PMID: 38417555. doi:10.1016/j.arth.2024.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。